Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
national blog main
national top stories
4
×
amgen
biotech
clinical trials
eli lilly
fda
life sciences
national
new york blog main
texas blog main
texas top stories
allergan
biohaven
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
detroit blog main
detroit top stories
eptinezumab
erenumab
fremanezumab
galcanezumab
indiana blog main
indiana top stories
migraine
migraine research foundation
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
wisconsin blog main
What
class
4
×
fda
migraine
new
approval
drug
medicines
nod
won
accelerator
adults
allergan
amgen
approved
arguments
big
buys
candidates
catch
center’s
commercialized
companies
competitors
decades
developed
drugs
gets
graduated
head
health
innovation
latest
lender
let’s
make
medical
meeting
microsoft
monday
neuro
Language
unset
Current search:
class
×
photo
×
" national top stories "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
TMCx, Microsoft Buys XOXCO, Self Lender Raises $10M & More TX Tech
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines